Antimicrobial Stewardship for Severe Infections Learning Pathway

The Antimicrobial Stewardship (AMS) for Severe Infections Learning Pathway has been re-launched!

It aims to facilitate understanding on the importance of antibiotic stewardship in the ICU, the role of a multidisciplinary and multi-professional approach, as well as the value of the diagnosis in the management of severe infections to avoid or reduce inappropriate use of antimicrobials.

A successful AMS requires international cooperation to control further development and spread of resistant pathogens, where the multidisciplinary and multi-professional approach becomes centre stage. The current training programme comes in line with the second key element of the EU guidelines on the prudent use of antimicrobials in human health “Antimicrobial prescribing and stewardship”.

The programme proposes a sustainable digital transformation and will ensure that participants are empowered to enjoy the opportunities that come with the digital decade.

Taskforce

Taskforce Edition 2024

Elsa AFONSO MSc, BSc (Hons), RN – HEA Fellow Senior Faculty of Health, Education, Medicine and Social Care, Cambridge, United Kingdom
Andrew CONWAY MORRIS MD, PhD, MRC – Clinician Scientist, University of Cambridge; Honorary Consultant in Intensive Care Medicine, Addenbrookes Hospital, Cambridge, United Kingdom; Chair, Infection Section, ESICM
Liesbet DE BUS MD PhD – Department of Critical Care Medicine, Ghent University Hospital, Ghent, Belgium
Cathrine McKENZIE PhD, FRPharmS – Consultant Pharmacist in Critical Care, Pharmacy and Critical Care, University Hospital Southampton, Tremona Road, Southampton, United Kingdom; Visiting Research Fellow, University of Southampton, School of Medicine, United Kingdom; Editor in Chief: Critical Illness; Member of the N&AHP Committee, ESICM
Jeroen SCHOUTEN MD, PhD – Intensivist, Radboud University Medical Centre, Nijmegen, the Netherlands; Senior research fellow, IQ Healthcare and chair, Europe’s Study group of Antimicrobial Stewardship (ESGAP)

Guest speakers:

Jan DE WAELE MD, PhD – Professor, Department of Critical Care Medicine/ Surgical Intensive Care Unit, Ghent University Hospital, Belgium; Sr. Clinical Investigator – FWO – Research Foundation Flanders; President-Elect, ESICM
Hendrik BRACHT MD, PhD – University Hospital Ulm, Dept. of Anesthesiology and Intensive Care Medicine, Ulm, Germany; Chair Infection Section, ESICM
Marc LEONE MD PhD – Department of Anesthesiology and Critical Care Medicine, Aix Marseille University, North Hospital, Assistance Publique – Hôpitaux de Marseille, Marseille, France; Deputy Chair Sepsis Section, ESICM

Programme

This hybrid training programme will allow participants to acquire, apply and integrate knowledge and skills through thematic sessions, fellowships & practical workshops.

The programme includes:

1. Kick-off webinar
- Date: February 28, 2024
- Time: at 16:00 h Central European Time -CET

2. A series of 3 LIVE online thematic sessions on the topic

Thematic Session 1: Multi-professional collaboration for an optimal patient management: how to establish an AMS team
- Date: March 8, 2024
- Time: 13:00 – 17:00 h CET
Thematic Session 2: The role and value of diagnosis in the management of severe infections
- Date: April 5, 2024
- Time: 13:00 – 17:00 h CEST
Thematic Session 3: Antibiotic Stewardship within the ICU
- Date: May 3, 2024
- Time: 13:00 – 17:00 h CEST

Certificates with 3 CME credits per session will be issued for those who either attend live or watch the recordings and complete the related quizzes.

3. Fellowships. A total of 25 fellowships will be conducted in centres around Europe, giving fellows the opportunity to experience antimicrobial stewardship in real-life settings and learn directly from experts. Fellowship-related costs (accommodation and travel) up to 1000 EUR/fellow will be reimbursed by ESICM.

Eligibility and applications for fellowships:

Applications open to participants from any professional background
Must be a member of the ESICM (so join up now if not already a member!)
Fellowships will be awarded on basis of application, attendance at all the 3 thematic sessions and highest performance in the quizzes.

Fellowship and mentors:

Evangelisches Krankenhaus Bielefeld, Germany – Hendrik BRACHT and the local team (September 02-06, 2024)
Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy – Massimo ANTONELLI, Gennaro DE PASCALE and the local team (November 18-22, 2024)
Hospital de São Francisco Xavier, CHLO, Lisbon, Portugal – Pedro POVOA and the local team (September 16-20, 2024)
Oxford University Hospitals NHS Foundation Trust University Hospital Southampton, London, United Kingdom – Daniele GIUDICI, Cathrine MCKENZIE, and the local team (September 16-20, 2024)
Radboud University Medical Centre, Nijmegen, The Netherlands – Jeroen SCHOUTEN and the local team (September 16-20, 2024)
University Hospital Carémeau Nimes,University Nimes, France – Claire ROGER and the local team (September 23-27, 2024)

Important! Priority will be given to those participants who did NOT benefit from an AMS fellowship in 2023.

4. Immersive Workshop through Virtual Reality to be carried out at LIVES 2024 in Barcelona

The workshop will immerse participants through Virtual Reality in realistic and safe learning environments, where they will face complex clinical scenarios to be solved with the ultimate objective of improving patients’ outcomes and positively impacting Antimicrobial Stewardship. ESICM will offer 25 rewards for LIVES 2024 in Barcelona to the best scoring participants.

Certificates with 4 CME credits will be issued for those who attend the workshop at LIVES.

Target

Eligibility and applications for fellowships:

Applications open to participants from any professional background
Must be a member of the ESICM (so join up now if not already a member!)
Fellowships will be awarded on basis of application, attendance at all the 3 thematic sessions and highest performance in the quizzes.

The programme targets ICU physicians and nurses, medical microbiologists and clinical pharmac(olog)ists. The programme will boost best practice exchange in a context where the approach to AMS varies significantly between countries and healthcare settings, and to contribute to a successful, multidisciplinary, and evidence-based AMS.